This is due for a nice little run up to 35-40p again as it looks like this might be commercialised at some point. I reckon even at its peak it will never get to the £1 mark but certainly looks like it is due a breakout again. Thank heavens we have not got the £4 figures being banded about as previously. Hope all those that I had charitable bets with paid up last Christmas. Anyway Good luck all as still hold an amount out of interest only. Liberium target looks realistic imo but over a £1 not sure on that. Hope you have all kept well and safe and your families. Carry on with care is my Motto. Crazy times. But guess everyone is getting even more than normal due to lockdown so great for FUM with an appealing product under current times even more so.
in the new play. Great results and further drilling in split rock. Really surprised that this has not gone double digit blue on this news as it is a great informative rns. I like these operators and this will one day be worth 20p so happy to wait even if it takes a few years. This will creep up on further drill results and touch the 2p mark again before year is out. Currently an insanely cheap entry point. This may well be swallowed up by another mining organisation eventually. Happy to keep topping up before investors actually cotton on to this one. Gold going to keep rising over the next decade so whats not to appreciate here.
yes the fat lady is just warming up her vocal chords in the wings. Two ways to take this latest rns. but she seems to be heading onto the stage imo. oil price so low so no incentive to use gas. Class action of some form should have happened when KF was in charge following **** up after **** up as reflected in the sp at the time imo.
they will look at alternative medicines to help in the aiding of patients treatment for covid 19 in the event that a vaccination may not be found for sometime. Once again some clarity from the company would be useful as to whether they see a possibility that it could aid covid 19 patients airways and help in their ability to breathe. But as fuhrer has pointed out the company cannot grasp an opportunity even when one presents itself. The lack of vision or ability to get sp enhancing news flow or publicity is staggering. I honestly do not know what they do to warrant their salaries. They need to get some communication or media company employed and maybe a director for communications imo. bemused by such seemingly inept ability to commercialise a drug which is continuously reflected in the sp. Still feel some news may be released before end of month. All keep safe and carry on carefully and with caution. "stay alert" against an invisible virus.... one of the worst pr blunders imo ever..... Verona Pharma has no PR as far as I am aware so unable to make any gaffs.
re wyld technology. This big investment has come in and due diligence will have been done. The amount says that they are looking to get rapid growth in the sector as it is as they say the flavour of the month and will be for a long time still to come. This could be a home run and the bases are all loaded and the sp could be knocked out the park. Also interesting article in Manchester evening news by health secretary re the isle of Wight and track and trace. rns by end of may but from which base, home run duly delivered.
see my 10.13 post yesterday it had been noted. Hope we can all live up to your surname from this investment. ;-) . Think many shall do well here. News flow on many fronts can come at any time. I would not be out as will come out of the blue.;-))
Yes that is the sort of rise I thought we would see. Well we are now with 8:1 ratio and exchange rate we are light by about 3p here equates to about 9%. So may see another small rise tomorrow. Would not be overly surprised to see another rns before month is out.
if Wedbush or any other analyst/broker changes their target for VRP/VRNA. You would expect after an endorsement from the FDA to start final phase three trials that they would up their target prices accordingly. Markets taking a little hit at present but with the new norm starting we should surely see a resumption in the upward trend as world economies show green shoots of progress once again. Still believe that the BOD and President or CEO etc etc should be looking at an ensifenterine and before/aftercare for covid connection. Does not mean it is not happening in the background but I expect not as no publicity but then that seems a dirty word to this company.
But as I speak sp on google finance live is showing Down 7.10% like I say this share is a total law unto itself following another great rns. Nothing short of mind boggling when it comes to this share. Will wait to see what VRNA does. The pulic relations and media department is still appalling imo. lse sp shows are totally out as per when you compare to real trade attempts on buys and sell also.
FVR is more than just your favourite. ;-). I would not bet against wyld being involved in the covid apptrack and trace and if it was not I am sure they will be looking at it. Would not believe all in the press however re track and trace. Announcement soon I am sure and it is no longer priced into tern sp as a factor so anything positive and this will sky rocket. I have noticed that the sp is suppressed ever morning and then fights back for a rally on most afternoons. I still think we have a big buyer in the background. I feel this is very much a 2018 scenario and the price will suddenly spike northwards and continue with a steady rise thereafter. 3 weeks max but will accumulate some more in early June.
20% or more on this sort of news and then drop back over the weeks but with potential further rns due this may hold and keep a steady rise. I have to say those Americans on the board the vice president and Ceo etc etc could instill confidence in the company by all investing some of their salaries. That would probably do more for the sp in the USA and here as it would show a sign that those involved have confidence in Ensifenterine and it would ENHANCE the Sp no pun intended. David Ebsworth is the only director to have put his money where his mouth is. You would think they were astute enough to invest in their own capabilities or they are all saving it for the next funding round or is it a partnership and then they will buy in. They need to at these levels invest if they have any business sense.
For sure that could be the cherry on the icing in terns portfolio but their are at least two other applications that could be evn greater money spinners here and a techy mate of mine having now been introduced to this share and done some research things we own 25% in a potential goldmine. So very much confident and happy to hold here. HE says if anywhere near real value is realised then this sp should be at least 30p even with the suppressed market currently. He has bought in and says he owes me a few pints for pointing this stock out. Good news could come from multiple areas...…. and out of the blue;-))
Thought we would get it at the end of june 2020. So for once ahead of schedule. Enhance. You can see why they have called it that as they expect to enhance the quality of life more than anything else I reckon. I expect VRP will be bought out for between 60p to mid 70's. A partnership could be possible or alternative non dilutive deal for percentage of royalties and that should send this up to 70's sp. I have to say however the flip side is that term sheets are already in place and just require signing and hence why the 4% share bonus to Dr Zac was so generous as the documents are awaiting signature and rns to follow. Remember if any deal was in the background it would have been on the outcome of the FDA report so do not be surprised to see another rns follow in days or weeks. The fact FDA has backed a phase three is extremely relevant and important and I do not expect to see any problems from the clinical trials of the drug. They may need to quarantine some of the trial patients but chances are most are probably in quarantine anyhow. Presuming they have a ready made list of people that have already been trialled unless they need to use new subjects. great if anyone can clarify that who has a pharmaceutical background. Izstar cannot remember if your good lady had a medical background or maybe getting confused. Anyway a very good rns and if it stays blue it will be a first. Lets see by 4.30 pm how the sp looks. did they have this prior to 4% being awarded in shares in which case I expect one or two good rns to follow. Hopefully please for those that hold many shares unlike myself that this for once is not another false dawn. GL izstar Fuhrer digger bewise and all LTH and others that are new that may make 100% from here.
granted 4% of the total ADR's. Fck me I need a doctor. Taking the ****. Even JAK left before he put his hand in his pocket. David Ebsworth must feel like he has been properly mugged off. Maybe he has got a massive payoff written into his contract that even eclipses that of Jak. When no new investors can be found they will conveniently blame C19 but they are the only people to blame iMO. The SP does not lie and nor the wages these past employees have taken for making no progress nor adding an ounce of value to the sp. They cannot even bother to tell the market the reasoning behind moving the offices to north Carolina. Every time I go past the local pig farm and I see the pigs with their noses in the trough I think of this investment. Funny how it has that association. Mind you at least the pigs make the farmer money
This company has been milked into oblivion. As much as it would shaft my few shares I would but for others heavily invested like izstar and buddy hell and the fuhrer I would love to see the main institutions sell down their share holdings as well as the investors in ADR's. IMO it would be great as they could crash the share price and see how it they like it as the board has done nothing but shaft investors imo and now it would be great to shaft them. The only thing that would **** me off from my own perspective is if this every paid shareholders handsomely as I have reduced massively. However more chance of seeing a flying pig (sorry if the board are not au fait with the terminology) IMO none of the previous incumbents have been up to the job and I seriously beginning to doubt the capabilities of this new bunch already. Can they not invest what little money we have left at Verona in buying a PPE manufacturer and then we can make some serious money or at least try and turn a profit. Once again imo we will be shunned by the markets who have sussed it out. Pity we all did not cotton on to this much earlier even the secretary did and she has not been to the offices for yonks or needs re training. I shall opt for the former. As it is not difficult to answer a phone after all. They cannot even inform the market as to why a company that has been portraying to have a first in class respiratory drug cannot trial the drug for pre care or after care for Covid 19 sufferers. Do we recruit from the Big Top. This is just a big fat cash cow to these people imo. Well at least we shall have no more CEO's and other high flyers in two years time because the money will have run out and these guys will be long gone. Sadly for many a massive financial lesson. But at least no other investors will see their saving obliterated as some including my self have seen over the years. Fortunately I have clawed back nearly the majority of my losses through very hard work. All new investors DYOR as many thought they had been thorough only to be mislead IMO by "significant shareholder value" statement and actually purchased more.
I believe this is one of the most interesting propositions that I have seen in a while. Very current and very marketable products going forward and even more so with C19 prevalence. Lots to like any single piece of good news could from one of many that they own a share in would see this go up 100% from current level inmo. But do you own research. I however have to agree that these businesses in this current climate could show exponential growth which will show in turn and translate through to tern sp.
Have just sold another holding to get some more in here. Cannot input any further funding here unless one off my other holdings goes up double digits. Next input will be early june with funds from wages. Completely concur with your sentiment and surprised more investors have not cottoned on to exactly what tern is and what it does. With the changing world we seem to be very well placed indeed.
looking at Wyld very happy to hear of up coming value. Yes imo not long to go for a rip snorting rns .Happy to be holding here and 15 to 20p probable. But with all companies under the tern umbrella growing and with highly innovative tech then might just do another top up. This week should another rns.
suggest you listen to the 2020 earnings conference call and you will nod off in no time imo. Do not even think I have got to the Q and A session at all. I think it is the monotone that imo does it for me. No proper questions asked like why was the admin expenses so high in comparison to previous year. Why does no one answer the London contact number... in which case why bother issuing it on the rns. are they aware that the receptionist is not carrying out the basic duties. Does that mean that the tea and biscuit person has also bunked off. has anyone actually frequent the London offices or were they all working remotely several years before covid19 ever appeared on the scene? Not one intellectual person even asked why the company which has a first in class respiratory drug had not looked at the prospect of using ensifenterine for covid pre admission of aftercare. How will they raise funds any one of all of the above or several of the above. Could the MDi phase 2B not start sooner..well yes it could but then do not really need it to continue phase 3. Well then why not imo save some money and ditch the trial and save what precious capital we have for phase 3. David Ebsworth must be looking forward to the dilution. Can they give us an update on what role certain members of the boards play because it seems to me that some are indeed duplicating. Why does someone not ask what value they put on ensifenterine as obviously has scared of any would be partners/buyers. Why do they not take a partner that can speed up the process to commercialization and take a bigger hit as in the long run we may get to commercialization quicker, do not know if anyone has told them that the patents only run for if I am correct another fifteen years. They maybe defunct by the time they get it marketed. Also why get expensive patents approved if commercialization comes after the patents expire. Why have they not stated the reason they have moved offices and put more meat on the bone. Try and get some positive press from it unless it is because the new CEO just lives in the neighbourhood in which case I get it. Why has such an opportunity as a major respiratory disease not helped the sp of a respiratory company, We would have done better if we produced PPE. Anyone would think Verona was an O and G explorer company not an R and D company that had a first in class respiratory drug. Is it any wonder that the sp does not rise. If this gets commercialised I reckon it would go up and stillimo manage to collapse the next day as it has done recently. It is hard to keep a straight face when discussing this share as I just want to laugh as it has been like a Comedy of Errors that knows no bounds and continues to be a total enigma imo. GLA we need that in spades. And keep safe and healthy for the next ten years and you may see it commercialise as it goes at a gravy train pace. That's a bit quicker than a snails pace. Enjoy VE day all and thanks all that gave so much. We need a WC CEO.